KB17A

N/A

Report date: 2025/04/29 09:25:32

Base Information

Drug NameKB17A

Drug Alias NameKB-17-AKB17A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionHLA class I histocompatibility antigen, alpha chain G inhibitors

TargetsHLA class I histocompatibility antigen, alpha chain G

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesKBio Inc

China Registration ClassN/A

Active CompaniesKBio Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A